Chang‐Yao Hsieh - Concepedia

Author

Chang‐Yao Hsieh

National Taiwan University Hospital

Also Known As

C Y Hsieh, CHANG-YAO HSIEH, CHANG‐YAO HSIEH, Chang-Yao Hsieh, Chang-yao Hsieh, Chang‐Yao Hsieh

107

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

National Taiwan University Hospital National Taiwan University Taipei Medical University Mackay Memorial Hospital Cathay General Hospital

About

Chang‐Yao Hsieh is an author at National Taiwan University Hospital specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	33	1.6K
2	Cell Biology	8	8	435
3	Public Health	5	5	191
4	Health Sciences	3	3	114
5	Engineering	1	1	1.7K

Chang‐Yao Hsieh

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Stability of curcumin in buffer solutions and characterization of its degradation products Ying‐Jan Wang, Min‐Hsiung Pan, Ann‐Lii Cheng, Journal of Pharmaceutical and Biomedical Analysis Materials ScienceEngineeringGreen ChemistryDegradation ProductsBuffer Solutions	1997	1.7K
The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway Lin‐Hung Wei, Min‐Liang Kuo, Chi‐An Chen, Oncogene CytokineCervical CancerApoptosisImmunologyAnti-apoptotic Role	2001	172
Serous ovarian carcinoma patients with high alpha‐folate receptor had reducing survival and cytotoxic chemo‐response Yu‐Li Chen, Ming‐Cheng Chang, Chia‐Yen Huang, Molecular Oncology	2011	139
Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma Shih‐Pei Huang, Ming‐Shiang Wu, Chia‐Tung Shun, Journal of Biomedical Science AngiogenesisMedicineEndothelial DysfunctionPathologyVascular Biology	2005	114
Interleukin-6 in Cervical Cancer: The Relationship with Vascular Endothelial Growth Factor Lin‐Hung Wei, Min‐Liang Kuo, Chi‐An Chen, Gynecologic Oncology AngiogenesisCervical CancerMedicineImmunologyPathology	2001	108
Serum Vascular Endothelial Growth Factor in Epithelial Ovarian Neoplasms: Correlation with Patient Survival Chi‐An Chen, Wen‐Fang Cheng, Chien‐Nan Lee, Gynecologic Oncology AngiogenesisMedicineGynecologyPathologyVascular Biology	1999	106
Genetic polymorphisms ofp53 andGSTP1,but notNAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus Jang‐Ming Lee, Yung‐Chie Lee, Shi‐Yi Yang, International Journal of Cancer	2000	101
Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease Chih‐Ming Ho, Ruby Yun‐Ju Huang, Tze-Chien Chen, Gynecologic Oncology Improved SurvivalMedicinePaclitaxel-platinum-based ChemotherapyGynecologyPathology	2004	98
Metronomic Chemotherapy Enhances Antitumor Effects of Cancer Vaccine by Depleting Regulatory T Lymphocytes and Inhibiting Tumor Angiogenesis Chi‐An Chen, Chih‐Ming Ho, Ming‐Cheng Chang, Molecular Therapy	2010	96
Pegylated liposomal doxorubicin (Lipo-Dox®) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up Hung‐Hsueh Chou, Kung‐Liahng Wang, Chi‐An Chen, Gynecologic Oncology Long-term Follow-upMedicineGynecologyLiposomal DoxorubicinTumor Targeting	2005	95

Page 1